Glenmark Pharmaceuticals Limited (NSE:GLENMARK)

Glenmark Pharmaceuticals Statistics

Total Valuation

NSE:GLENMARK has a market cap or net worth of INR 557.18 billion. The enterprise value is 542.51 billion.

Market Cap	557.18B
Enterprise Value	542.51B

Important Dates

The last earnings date was Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	Oct 3, 2025

Share Statistics

NSE:GLENMARK has 282.20 million shares outstanding. The number of shares has increased by 0.04% in one year.

Current Share Class	282.20M
Shares Outstanding	282.20M
Shares Change (YoY)	+0.04%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	3.12%
Owned by Institutions (%)	37.62%
Float	141.49M

Valuation Ratios

The trailing PE ratio is 52.31 and the forward PE ratio is 24.18. NSE:GLENMARK's PEG ratio is 1.08.

PE Ratio	52.31
Forward PE	24.18
PS Ratio	3.37
PB Ratio	5.82
P/TBV Ratio	7.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.08

Enterprise Valuation

EV / Earnings	50.94
EV / Sales	3.29
EV / EBITDA	13.14
EV / EBIT	14.05
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.13
Debt / EBITDA	0.30
Debt / FCF	n/a
Interest Coverage	16.59

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	31.58%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	6.00%
Revenue Per Employee	10.45M
Profits Per Employee	674,106
Employee Count	15,800
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:GLENMARK has paid 5.40 billion in taxes.

Income Tax	5.40B
Effective Tax Rate	33.64%

Stock Price Statistics

The stock price has increased by +29.57% in the last 52 weeks. The beta is 0.29, so NSE:GLENMARK's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	+29.57%
50-Day Moving Average	1,988.94
200-Day Moving Average	1,866.36
Relative Strength Index (RSI)	43.29
Average Volume (20 Days)	505,196

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:GLENMARK had revenue of INR 165.10 billion and earned 10.65 billion in profits. Earnings per share was 37.74.

Revenue	165.10B
Gross Profit	116.74B
Operating Income	38.62B
Pretax Income	16.05B
Net Income	10.65B
EBITDA	40.30B
EBIT	38.62B
Earnings Per Share (EPS)	37.74

Balance Sheet

The company has 26.90 billion in cash and 12.24 billion in debt, with a net cash position of 14.66 billion or 51.95 per share.

Cash & Cash Equivalents	26.90B
Total Debt	12.24B
Net Cash	14.66B
Net Cash Per Share	51.95
Equity (Book Value)	95.82B
Book Value Per Share	339.57
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 70.71%, with operating and profit margins of 23.39% and 6.45%.

Gross Margin	70.71%
Operating Margin	23.39%
Pretax Margin	9.72%
Profit Margin	6.45%
EBITDA Margin	24.41%
EBIT Margin	23.39%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.26%.

Dividend Per Share	5.00
Dividend Yield	0.26%
Dividend Growth (YoY)	100.00%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-0.04%
Shareholder Yield	0.21%
Earnings Yield	1.91%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 10, 2007. It was a forward split with a ratio of 2.

Last Split Date	Sep 10, 2007
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	2